US$ 22.35
physiology of glp 1 Mechanisms by which GLP-1 agonists may exert beneficial effects on the The Physiology of Glucagon-like Peptide
Description
Methods This is a cohort study combining several population-wide databases and covering a Spanish population of five million inhabitants, including all adults with obesity who initiated treatment with either GLP-1RA or SGLT-2i for type 2 diabetes from 2015 to 2021

phosphorus: 20% of the DV

All participants underwent continuous glucose monitoring (CGM) for three consecutive days, then TIR and glycemic variability (GV) parameters were evaluated

As newer versions continue to be developed, researchers are asking whether these next generation drugs may be even more effective than current options.
